celecoxib has been researched along with Carcinoma, Lewis Lung in 5 studies
Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of this study is to investigate the effect of FLP alone or in combination with celecoxib in the prevention of lung cancer progression by Cyclooxygenase (Cox)-2 mediated tumor inflammatory microenvironment in vivo." | 1.42 | Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model. ( Bao, Y; Gao, Y; Guo, Q; He, S; Hirasaki, Y; Hou, W; Hua, B; Li, C; Li, W; Liu, R; Pei, Y; Qi, X; Zhang, Y; Zheng, H, 2015) |
| " Chronic administration of a cyclooxygenase (COX)-2 inhibitor is effective to bone cancer-related pain." | 1.37 | Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice. ( Akira, S; DeClerck, YA; Hayashi, I; Hosono, K; Isono, M; Majima, M; Okamoto, H; Sakagami, H; Suzuki, T; Uematsu, S, 2011) |
| "Celecoxib is a potent nonsteroid anti-inflammatory drug (NSAID) that has demonstrated great promise in cancer chemoprevention and treatment." | 1.37 | Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A₂ and peroxisome proliferator-activated receptor gamma. ( Chen, L; Li, O; Li, W; Li, ZJ; Shao, D; Shi, Z; Wang, KZ; Xu, ZG; Zhang, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogawa, F | 1 |
| Amano, H | 1 |
| Eshima, K | 1 |
| Ito, Y | 1 |
| Matsui, Y | 1 |
| Hosono, K | 2 |
| Kitasato, H | 1 |
| Iyoda, A | 1 |
| Iwabuchi, K | 1 |
| Kumagai, Y | 1 |
| Satoh, Y | 1 |
| Narumiya, S | 1 |
| Majima, M | 2 |
| Liu, R | 1 |
| Zheng, H | 1 |
| Li, W | 2 |
| Guo, Q | 1 |
| He, S | 1 |
| Hirasaki, Y | 1 |
| Hou, W | 1 |
| Hua, B | 1 |
| Li, C | 1 |
| Bao, Y | 1 |
| Gao, Y | 1 |
| Qi, X | 1 |
| Pei, Y | 1 |
| Zhang, Y | 1 |
| Park, W | 1 |
| Oh, YT | 1 |
| Han, JH | 1 |
| Pyo, H | 1 |
| Isono, M | 1 |
| Suzuki, T | 1 |
| Hayashi, I | 1 |
| Sakagami, H | 1 |
| Uematsu, S | 1 |
| Akira, S | 1 |
| DeClerck, YA | 1 |
| Okamoto, H | 1 |
| Zhang, M | 1 |
| Xu, ZG | 1 |
| Shi, Z | 1 |
| Shao, D | 1 |
| Li, O | 1 |
| Li, ZJ | 1 |
| Wang, KZ | 1 |
| Chen, L | 1 |
5 other studies available for celecoxib and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Prostanoid induces premetastatic niche in regional lymph nodes.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Celecoxib; Cell Line, Tumor; Chemokine CXCL12 | 2014 |
Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model.
Topics: Animals; Carcinoma, Lewis Lung; Celecoxib; Cyclooxygenase 2; Drugs, Chinese Herbal; Heterografts; In | 2015 |
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2 | 2008 |
Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice.
Topics: Animals; Behavior, Animal; Bone Neoplasms; Calcitonin Gene-Related Peptide; Carcinoma, Lewis Lung; C | 2011 |
Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A₂ and peroxisome proliferator-activated receptor gamma.
Topics: Animals; Apoptosis; Arachidonic Acids; Area Under Curve; Carcinoma, Lewis Lung; Celecoxib; Cell Line | 2011 |